ADIM
LTHM

Alpha DNA Investment Management’s Livent Corporation LTHM Stock Holding History

Alpha DNA Investment Management’s Portfolio LTHM Stock Details LTHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-18,082
Closed -$554K – 212
2022
Q3 		$554K Buy
+18,082
New +$507K 0.46% 101
2022
Q2 		– Sell
-48,497
Closed -$1.26M – 182
2022
Q1 		$1.26M Buy
+48,497
New +$1.13M 0.89% 36

Other funds holding LTHM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Alpha DNA Investment Management's LTHM Position: Q4 2022 in Review

Alpha DNA Investment Management sold out of Livent Corporation (LTHM) in Q4 2022, closing a stake of 18,082 shares — an estimated $554K sold.

Alpha DNA Investment Management first reported a position in LTHM in Q1 2022 and held it in 2 quarters. The position peaked at $1.26M in Q1 2022. 426 funds tracked by Wall St. Rank hold LTHM as of Q4 2022.

  • Alpha DNA Investment Management reported no remaining Livent Corporation position as of Q4 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 18,082 Livent Corporation shares in Q4 2022, an estimated $554K.
  • Alpha DNA Investment Management first reported a position in Livent Corporation in Q1 2022 and held it in 2 quarters.
  • Alpha DNA Investment Management's Livent Corporation position peaked at $1.26M in Q1 2022.
  • 426 funds tracked by Wall St. Rank held Livent Corporation as of Q4 2022.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.